Skip to main content
AYTU BIOPHARMA, INC logo

AYTU BIOPHARMA, INC — Investor Relations & Filings

Ticker · AYTU ISIN · US0547548745 US Manufacturing
Filings indexed 890 across all filing types
Latest filing 2022-12-27 Board/Management Inform…
Country US United States of America
Listing US AYTU

About AYTU BIOPHARMA, INC

https://aytubio.com/

Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics. The company concentrates on advancing innovative medicines for complex central nervous system (CNS) diseases, with a particular emphasis on treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and Major Depressive Disorder (MDD). Its business model involves identifying, acquiring, and commercializing new products to improve the quality of life for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated December 22, 2022, reporting the departure of a board member, Gary Cantrell, from the company's Board of Directors effective December 31, 2022. The content focuses on management changes, specifically a director's retirement and the initiation of a search for a new board member. There is no financial data, earnings information, or other report types present. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-12-27 English
FORM 4
Director's Dealing
2022-12-23 English
FORM 4
Director's Dealing
2022-12-23 English
FORM 4
Director's Dealing
2022-12-23 English
FORM 4
Director's Dealing
2022-12-23 English
FORM 4
Director's Dealing
2022-12-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.